MENU
SKYE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Skye Bioscience (SKYE) Ownership - Who owns Skye Bioscience?
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
98.6M
P/E Ratio
6.13
Total Cash
67.41M
Projected Growth
N/A
Total Debt
190.99K
Revenue
N/A
Risk (Beta)
2.94
Dividend Yield
N/A
Total Cash/Share
2.22
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SKYE
Capitalization
98.6M
P/E Ratio
6.13
Risk (Beta)
2.94
Dividend Yield
N/A
Total Cash
67.4M
Total Cash/Share
2.22
Total Debt
191K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
75.8M
P/B Ratio
1.30
Cash Flow
N/A
Earnings
0.53
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
30.3K
Current Ratio
14.19
Current Revenue Per Employee
23699.00
Dividends Per Share - Security
N/A
EBITDA
-19.64M
Float
N/A
Float - Current
N/A
Gross Income Margin
72.69
Revenue To Assets
-43.73
Shares Held By Institutions
208M
Shares Outstanding - Current
30.3M
Total Liabilities
5.73M
Total Volume MTD
N/A
Value
N/A
Gain YTD
19.485
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information